VUC

(2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid

Created:2023-08-18
Last modified:  2025-02-12

Find related ligands:

Chemical Details

Formal Charge0
Atom Count37
Chiral Atom Count1
Bond Count37
Aromatic Bond Count6
2D diagram of VUC

Chemical Component Summary

Name(2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid
Synonymsmelphalan
Systematic Name (OpenEye OEToolkits)(2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid
FormulaC13 H18 Cl2 N2 O2
Molecular Weight305.2
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385N[CH](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O
SMILESOpenEye OEToolkits2.0.7c1cc(ccc1CC(C(=O)O)N)N(CCCl)CCCl
Canonical SMILESCACTVS3.385 N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O
Canonical SMILESOpenEye OEToolkits2.0.7 c1cc(ccc1C[C@@H](C(=O)O)N)N(CCCl)CCCl
InChIInChI1.06 InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1
InChIKeyInChI1.06 SGDBTWWWUNNDEQ-LBPRGKRZSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB01042 
NameMelphalan
Groups approved
DescriptionMelphalan is a nitrogen mustard or bischloroethylamine type alkylating agent.[L40928] It was first synthesized in the early 1950s by substituting L-phenylalanine for the methyl group on nitrogen mustard.[A261150, A261155] Melphalan is used in the treatment of multiple myeloma and ovarian carcinoma.[L40928] It is also used for high-conditioning before hematopoietic stem cell transplant.[L47890] It is also used to treat uveal melanoma with unresectable hepatic metastases.[L47895]
Synonyms
  • p-N,N-bis(2-chloroethyl)amino-L-phenylalanine
  • Melphalan
  • Melfalano
  • Phenylalanine nitrogen mustard
  • L-Phenylalanine mustard
Brand Names
  • Taro-melphalan
  • Alkeran
  • Phelinun
  • Melphalan
  • Hepzato Kit
IndicationMelphalan is indicated for use as a high-dose conditioning treatment prior to hematopoietic stem cell transplantation in patients with multiple myeloma.[L47890] It is also indicated for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary.[L40928] Melphalan is a component of HEPZATO KIT, a liver-directed therapy indicated for the treatment of adults with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation.[L47895]
Categories
  • Alkylating Activity
  • Alkylating Drugs
  • Amino Acids
  • Amino Acids, Aromatic
  • Amino Acids, Cyclic
ATC-CodeL01AA03
CAS number148-82-3

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
DNA-unknowncross-linking/alkylation
AlbuminMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...unknownbinder
Alpha-1-acid glycoprotein 1MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDRITGKWFYIASAF...unknownbinder
Solute carrier family 22 member 3MPSFDEALQRVGEFGRFQRRVFLLLCLTGVTFAFLFVGVVFLGTQPDHYW...unknowninhibitor
Large neutral amino acids transporter small subunit 1MAGAGPKRRALAAPAAEEKEEAREKMLAAKSADGSAPAGEGEGVTLQRNI...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 6918992, 460612
ChEMBL CHEMBL852
ChEBI CHEBI:28876